IL18 and obesity due to melanocortin 4 receptor deficiency: In addition, patients with elevated pre-RT IL-18 levels and obesity experienced the highest odds of post-RT pain (OR = 3.97, 95% CI: 1.98-7.98) and RT-related pain (OR = 2.84, 95% CI: 1.32-6.09), suggesting a potential combined effect.